Fulgent Genetics
FLGT
201 hedge funds and large institutions have $380M invested in Fulgent Genetics in 2023 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 61 increasing their positions, 67 reducing their positions, and 31 closing their positions.
344% more call options, than puts
Call options by funds: $19.8M | Put options by funds: $4.46M
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
0.72% more ownership
Funds ownership: 46.82% → 47.54% (+0.72%)
9% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 67
6% less funds holding
Funds holding: 214 → 201 (-13)
26% less capital invested
Capital invested by funds: $515M → $380M (-$134M)
32% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$11.8M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$8.64M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$6.41M |
| 4 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$5.69M |
| 5 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
+$3.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$9.27M |
| 2 |
Nuveen
Charlotte,
North Carolina
|
-$5.02M |
| 3 |
KLC
Kent Lake Capital
Reno,
Nevada
|
-$3.7M |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$3.46M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$1.97M |
FLGT Hedge Fund Activity: Q3 2023 in Review
201 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q3 2023, worth a combined $380M — down 26% from $515M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of FLGT and 21 opened new positions — a net loss of 10 holders — while 67 trimmed existing stakes and 61 added.
The largest buyer was Park West Asset Management, opening a new position worth an estimated $11.8M. The largest seller was Citadel Advisors, cutting an estimated $9.27M.
- 201 institutional investors held Fulgent Genetics (FLGT) as of Q3 2023, down from 214 in Q2 2023.
- Funds reported $380M of Fulgent Genetics stock for Q3 2023, down 26% quarter-over-quarter.
- 21 funds opened new Fulgent Genetics positions in Q3 2023 and 31 closed out, a net change of -10 holders.
- The largest Fulgent Genetics buyer in Q3 2023 was Park West Asset Management, an estimated $11.8M added.
- The largest Fulgent Genetics seller in Q3 2023 was Citadel Advisors, an estimated $9.27M sold.
Based on aggregated 13F filings for Q3 2023.